Please assess the completion status of the following clinical trial:

Trial Title: Vortioxetine vs Sertraline in Mexicans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals had to be between 18 and 85 years of age~* Clinical diagnosis of type 2 diabetes mellitus based on the American Diabetes Association criteria,~* They had to receive anti-diabetic treatment, Clinical diagnosis of major depressive episode according Association Diagnostic and Statistical Manual of Mental Disorders, five edition (DSM-V)~* Ratings scale score ≥ 14 by means of Hamilton Depression scale (HAM-D)~* Patients had to give verbal and written informed consent for this study~Exclusion Criteria:~* Neurological illness~* Psychoactive medications~* Type I diabetes~* Active suicidal ideation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Vortioxetine therapy (Type: EXPERIMENTAL): patients who gave informed consent and met the inclusion criteria were attended by a psychiatrist. The pharmacological management were randomly assigned: these group of patients received vortioxetine (10 mg/day) for 8 weeks, in addition, the patients maintained their anti-diabetic treatment (oral hypoglycemic or insulin)
- Sertraline therapy (Type: EXPERIMENTAL): patients who gave informed consent and met the inclusion criteria were attended by a psychiatrist. The pharmacological management were randomly assigned: these group of patients received sertraline (75 mg / day) for 8 weeks, in addition, the patients maintained their anti-diabetic treatment (oral hypoglycemic or insulin)

Based on this trial design, predict the completion outcome and termination type (if applicable).